Recurrent or Metastatic Nasopharyngeal Cancer
2 clinical trials · Condition
◉ Watch Recurrent or Metastatic Nasopharyngeal Cancer
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (NCT03924986) | BeiGene | 2019-03-27 |
Track Recurrent or Metastatic Nasopharyngeal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.